Immucor and Alverno Clinical Laboratories Sign Five-Year Automation Agreement

NORCROSS, Ga., May 27 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD),
a global leader in providing automated instrument-reagent systems to the blood
transfusion industry, announced today that it has signed a five-year agreement
with Alverno Clinical Laboratories, LLC, one of the largest regional hospital
laboratory integrated delivery systems in the nation, serving 27 hospitals in
Illinois and Indiana.

Under the agreement, Alverno is standardizing pre-transfusion testing in 26
facilities with Immucor automation through the acquisition of 24 Echo
instruments and 2 Capture Workstations. Additionally, Immucor will be the
primary source for Alverno's blood bank reagent needs.

"We are pleased to partner with such an innovative organization as Alverno,"
stated Dr. Gioacchino De Chirico, President and Chief Executive Officer of
Immucor. "We believe that integrated delivery networks can achieve significant
benefits both in terms of improving operational efficiency and improving
patient safety through standardizing their blood bank operations with Immucor
automation."

"Our goal is to produce accurate and timely test results while implementing
standardized best practices across all laboratory sites," stated Sam Terese,
Chief Operating Officer of Alverno Clinical Laboratories. "We chose Immucor
due to the exceptional functionality of the Echo instrument and its fit with
LEAN operations as well as Immucor's commitment to improving transfusion
medicine."

Immucor's innovative automation strategy provides scalable solutions to meet
the needs of all blood banks, regardless of size. Immucor has continually
invested in automation since 1998, most recently with the Echo instrument. The
Echo, which is designed for smaller volume laboratories, features a broad test
menu, instant access and the industry's fastest turnaround times.

About Alverno Clinical Laboratories
Located in Hammond, In., Alverno Clinical Laboratories, LLC is one of the
largest regional hospital laboratory integrated delivery systems in the
nation. Alverno's operations include a regional core laboratory, 27 hospital
laboratories, and a network of patient service centers in both Indiana and
Illinois. Alverno is a joint venture of the Sisters of St. Francis Health
Services, Inc., Resurrection Health Care and Provena Health. For more
information on Alverno, please visit our website at
www.alvernoclinicallabs.com.

About Immucor
Founded in 1982, Immucor manufactures and sells a complete line of reagents
and systems used by hospitals, reference laboratories and donor centers to
detect and identify certain properties of the cell and serum components of
blood prior to transfusion. Immucor markets a complete family of automated
instrumentation for all of its market segments. For more information on
Immucor, please visit our website at www.immucor.com.

SOURCE Immucor, Inc.

Immucor Contact: Michele Howard, +1-770-441-2051; or Alverno Contact: Bernard
Henry, +1-219-989-3700